REAL-WORLD EVIDENCE:
DATA ANALYTICS

Evidera has been actively involved in leading the development of guidelines for good database selection and use in pharmacoepidemiologic research. Read More

Services & Products

  • Publications

    Publication

    Prescriber Compliance With Liver Monitoring Guidelines for Pazopanib in the Postapproval Setting: Results From a Distributed Research Network. J Patient Saf. 2017 Apr 20. doi: 10.1097/PTS.0000000000000332. [Epub ahead of print] ABSTRACT

    Publication

    A New Framework for Evaluating the Health Impacts of Treatment for Gaucher Disease Type 1. Orphanet J Rare Dis. 2017 Feb 20;12(1):38. doi: 10.1186/s13023-017-0592-6. ABSTRACT

    Publication

    Initiation of Triple Therapy Maintenance Treatment among Patients with COPD in the US. Int J Chron Obstruct Pulmon Dis. 2016 Dec 22;12:73-83. doi: 10.2147/COPD.S122013. eCollection 2017. ABSTRACT
    See More
  • Webinars

    Webinar

    Pregnancy Registries and Lactation Studies: Best Practices to Support Product Labeling

    Presenters: Deborah Covington, DrPH, Executive Director, Real-World Evidence, Evidera

    Additional Info
    Contact us for slides
    Recording

    Webinar

    Implementing a Common Data Model in a Real-World Informatics and Analytics Environment: Headwinds or Smooth Sailing?

    Presenters: Stephanie (Steph) Reisinger, President and General Manager, Evalytica; and, Radek Wasiak, PhD, Vice President and General Manger, Real-World Evidence and Meta Research, Evidera

    Additional Info
    Contact us for slides
    Recording

    Webinar

    Post-Authorisation Safety Studies: PASS the Word Around

    Presenters: Sreeram (Ram) Ramagopalan, PhD (formerly of Evidera); Javier Cid, MD, Research Scientist, Real-World Evidence, Evidera

    Additional Info
    Contact us for slides
    Recording
    See More
  • White Papers

    Whitepaper

    Medical Specialty Societies - An Emerging Source of Real-World Evidence

    Authors: Vernon F. Schabert, PhD, Evidera

    Year: 2016

    View

    Whitepaper

    The Importance of Real-World Evidence Generation in Oncology

    Authors: Dara Stein, MSc, Evidera; Linda Ross, MPH, Evidera; Krista Payne, MEd, Evidera

    Year: 2016

    View

    Whitepaper

    Time to Get Real about Real-World Data in HEOR and Epidemiological Research

    Authors: Radek Wasiak, PhD Vice President and General Manager, Real-World Evidence and Meta Research, Evidera

    Year: 2016

    View
    See More
  • Presentations

    Poster

    Predictors of Treatment Adherence and Discontinuation in Department of Defense (DoD) Health Care Beneficiaries Treated for Chronic Hepatitis C 2004-2013

    AASLD The Liver Meeting 2015:

    San Francisco, CA, USA
    13-Nov-2015

    Authors/Presenters: Teltsch D, Walker DR, Nordstrom B, Fraeman K, Kronmann K, St. Clair KJ

    Year: 2015

    Poster

    Patterns of Utilization and Cost of Prostacylins for Pulmonary Arterial Hypertension

    ISPOR 18th Annual European Congress – 2015:

    Milan, Italy
    07-Nov-2015

    Authors/Presenters: Schneider G, Rotella P, Raspa S, Berger A, Pruett J, Murphy B, Lickert C, Drake W

    Year: 2015

    Poster

    Evaluation of EU Post-Authorization Safety Studies Using EU-RMP / European Public Assessment Reports: Analysis, Trends and Implications

    ICPE 2015:

    Boston, MA, USA
    22-Aug-2015

    Authors/Presenters: Neasham D, Baradaran S, Chalkiadaki C, Sadasivan R, Nordstrom B, Reynolds M

    Year: 2015

    See More
  • Fact Sheets

    Fact Sheet

    Real-World Evidence: Data Analytics
    Download

Evidera’s team of researchers extract relevant real-world data from existing healthcare information sources and analyze it to provide clear descriptions of treatment patterns, resource use and costs associated with the disease and its treatment, and insight into the factors that determine outcomes. With a team consisting of health economists, epidemiologists, biostatisticians and clinicians, we are able to conduct a range of studies to:

  • Understand the natural history of disease (e.g., incidence, prevalence)
  • Determine the unmet need by evaluating the burden or cost of illness
  • Quantify product-specific or comparative safety, effectiveness, adherence and other outcomes
    • Support post-marketing assessment and commitments
    • Define need and scope of risk assessment / management
    • Identify and quantify the patient population of interest and risk factors for adverse events
    • Evaluate appropriateness of drug utilization
  • Understand treatment patterns and their effects on patient, clinical and economic outcomes
  • Examine how the definition of an event or condition may have affected key metrics, such as prevalence and incidence
  • Provide estimates for inputs used in health economic evaluations

Evidera does not limit its analyses to a proprietary database. Instead, we are able to work with nearly any dataset. Our researchers critically assess the available databases to identify those that will yield the best information for your needs. We have a deep understanding of, and experience with, data sources across 20+ countries. This includes the major databases across North America and Europe, and we engage other data providers around the world as needed (e.g., Brazil, Japan, Korea, China, Australia, Taiwan).

We understand and are able to analyze large claims databases and electronic medical records as well as combinations of these and other data sources. When retrospective data are not enough, we can supplement them with prospective data collection. When it’s time to communicate the findings, Evidera excels in the development of audience-appropriate dissemination materials for decision makers, scientists, clinicians and consumers.

Offerings

Database Analytics

Identify, analyze and understand treatment patterns, natural history of disease, risk of clinical outcomes and risk factors.

Real-World Data Identification

Identify the best data sources to address research questions and develop a real-world data strategy.

Advanced Statistical Modeling and Predictive Analytics

Go beyond the surface of data to see important patterns and associations.

Post Hoc and Exploratory Analytics of Trial and Observational Data

Closely examine the product’s trial or observational data to unlock hidden value.

Coding Algorithm Development

Determine and optimize definitions of key clinical variables and outcomes for database studies to ensure quality definitions for those events.

Real-World Evidence: Data Analytics Experts

Services & Products

  • Publications

    Publication

    Prescriber Compliance With Liver Monitoring Guidelines for Pazopanib in the Postapproval Setting: Results From a Distributed Research Network. J Patient Saf. 2017 Apr 20. doi: 10.1097/PTS.0000000000000332. [Epub ahead of print] ABSTRACT

    Publication

    A New Framework for Evaluating the Health Impacts of Treatment for Gaucher Disease Type 1. Orphanet J Rare Dis. 2017 Feb 20;12(1):38. doi: 10.1186/s13023-017-0592-6. ABSTRACT

    Publication

    Initiation of Triple Therapy Maintenance Treatment among Patients with COPD in the US. Int J Chron Obstruct Pulmon Dis. 2016 Dec 22;12:73-83. doi: 10.2147/COPD.S122013. eCollection 2017. ABSTRACT
    See More
  • Webinars

    Webinar

    Pregnancy Registries and Lactation Studies: Best Practices to Support Product Labeling

    Presenters: Deborah Covington, DrPH, Executive Director, Real-World Evidence, Evidera

    Additional Info
    Contact us for slides
    Recording

    Webinar

    Implementing a Common Data Model in a Real-World Informatics and Analytics Environment: Headwinds or Smooth Sailing?

    Presenters: Stephanie (Steph) Reisinger, President and General Manager, Evalytica; and, Radek Wasiak, PhD, Vice President and General Manger, Real-World Evidence and Meta Research, Evidera

    Additional Info
    Contact us for slides
    Recording

    Webinar

    Post-Authorisation Safety Studies: PASS the Word Around

    Presenters: Sreeram (Ram) Ramagopalan, PhD (formerly of Evidera); Javier Cid, MD, Research Scientist, Real-World Evidence, Evidera

    Additional Info
    Contact us for slides
    Recording
    See More
  • White Papers

    Whitepaper

    Medical Specialty Societies - An Emerging Source of Real-World Evidence

    Authors: Vernon F. Schabert, PhD, Evidera

    Year: 2016

    View

    Whitepaper

    The Importance of Real-World Evidence Generation in Oncology

    Authors: Dara Stein, MSc, Evidera; Linda Ross, MPH, Evidera; Krista Payne, MEd, Evidera

    Year: 2016

    View

    Whitepaper

    Time to Get Real about Real-World Data in HEOR and Epidemiological Research

    Authors: Radek Wasiak, PhD Vice President and General Manager, Real-World Evidence and Meta Research, Evidera

    Year: 2016

    View
    See More
  • Presentations

    Poster

    Predictors of Treatment Adherence and Discontinuation in Department of Defense (DoD) Health Care Beneficiaries Treated for Chronic Hepatitis C 2004-2013

    AASLD The Liver Meeting 2015:

    San Francisco, CA, USA
    13-Nov-2015

    Authors/Presenters: Teltsch D, Walker DR, Nordstrom B, Fraeman K, Kronmann K, St. Clair KJ

    Year: 2015

    Poster

    Patterns of Utilization and Cost of Prostacylins for Pulmonary Arterial Hypertension

    ISPOR 18th Annual European Congress – 2015:

    Milan, Italy
    07-Nov-2015

    Authors/Presenters: Schneider G, Rotella P, Raspa S, Berger A, Pruett J, Murphy B, Lickert C, Drake W

    Year: 2015

    Poster

    Evaluation of EU Post-Authorization Safety Studies Using EU-RMP / European Public Assessment Reports: Analysis, Trends and Implications

    ICPE 2015:

    Boston, MA, USA
    22-Aug-2015

    Authors/Presenters: Neasham D, Baradaran S, Chalkiadaki C, Sadasivan R, Nordstrom B, Reynolds M

    Year: 2015

    See More
  • Fact Sheets

    Fact Sheet

    Real-World Evidence: Data Analytics
    Download
Back to Top